DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Cardiovascular Disease 104

DAIC

OCTOBER 16, 2024

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). This is a positive step towards improved patient care,” said Ahmad Slim, MD, FSCCT, director of imaging at Pulse Heart Institute and chair of the HPPC.

CMS 52

CMS Medicare Plaque Chest Pain 52

DAIC

JULY 18, 2024

The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C. Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game changer as a clinician. F.A.C.C. “The

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Medicare 111

DAIC

MARCH 7, 2024

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 Halpern, MD, and Vijay M.

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

When providers and clinicians have access to the best quality data, patient care improves. After a medical device or intervention has been proven to be safe and effective and reasonable and necessary for coverage, CED requires innovators to monitor how their technology performs in the real world. Learn more at sts.org.

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

DAIC

JUNE 12, 2024

Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries.

Stent 105

Stent Stents Anatomy Ultrasound 105

GEMMS

APRIL 8, 2024

With the recent changes to MIPS reporting requirements, healthcare providers seek innovative solutions to streamline their reporting processes while maximizing incentives and improving patient care. What is MIPS?

Medicare 52

Medicare Innovation Patient Care Medicaid 52